ืคื™ืœื˜ืจื™ื

ืคื™ืœื˜ืจื™ื

โ‚ช
ืœ
โ‚ช
6 ืžื•ืฆืจื™ื
ืžื™ื™ืŸ ืข"ื™
ืžื™ื™ืŸ ืข"ื™
ื’ืจื™ืŸ ืคืœื™ื™ืก ื”ื˜ื•ืจืคืช ื”ื™ืจื•ืงื”-ืžืœื›ื•ื“ืช ื–ื‘ื•ื‘ื™ื ื’ื“ื•ืœื”-pharm2u
ื’ืจื™ืŸ ืคืœื™ื™ืก ืžืœื›ื•ื“ืช ืขื›ื‘ืจื™ื ืžื™ื ื™ ื”ื•ืžื ื™ืช-pharm2u
ื”ืœื•ื—ื™ืช ื”ืฆื”ื•ื‘ื” L ืžืœื›ื•ื“ืช ื“ื‘ืง ืžืงืฆื•ืขื™ืช-pharm2u
ืžืœื›ื•ื“ืช ืขืฉ ื”ืžื–ื•ืŸ ืขื ืคืจื•ืžื•ืŸ-pharm2u
ืื–ืœ ื”ืžืœืื™
ืงื•ื•ื™ืŸ ื’'ื™ืœ ืœื”ื“ื‘ืจืช ื ืžืœื™ื-pharm2u
ืงื™ื ื’ ื’'ื™ืœ ืœื”ื“ื‘ืจืช ืชื™ืงื ื™ื-pharm2u

ืฉื™ืจื•ืช ืžืฉืœื•ื—ื™ื ืื™ื›ื•ืชื™ ื•ืžื”ื™ืจ

ืœื‘ื—ื™ืจืชื›ื: ืžืฉืœื•ื— ืขื ืฉืœื™ื— ืขื“ ื”ื‘ื™ืช ,ืžืฉืœื•ื— ืœื ืงื•ื“ืช ืื™ืกื•ืฃ ืื• ืื™ืกื•ืฃ ืขืฆืžื™. ืžืขืœ 399 ืฉ"ื—, ื”ืžืฉืœื•ื— ืœื ืง' ืื™ืกื•ืฃ ื—ื™ื ื